1. Home
  2. AIV vs XNCR Comparison

AIV vs XNCR Comparison

Compare AIV & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$4.25

Market Cap

837.1M

Sector

Real Estate

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$11.07

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIV
XNCR
Founded
1975
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
837.1M
881.9M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
AIV
XNCR
Price
$4.25
$11.07
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$10.00
$22.33
AVG Volume (30 Days)
1.2M
678.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
87.41%
N/A
EPS Growth
616.00
65.36
EPS
N/A
N/A
Revenue
$138,486,000.00
$125,576,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.65
52 Week Low
$3.94
$6.92
52 Week High
$8.87
$18.69

Technical Indicators

Market Signals
Indicator
AIV
XNCR
Relative Strength Index (RSI) 49.72 38.02
Support Level $4.03 $11.02
Resistance Level $4.30 $13.28
Average True Range (ATR) 0.06 0.74
MACD 0.00 -0.18
Stochastic Oscillator 54.29 9.80

Price Performance

Historical Comparison
AIV
XNCR

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: